Cargando…

Network module‐based drug repositioning for pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by pulmonary vascular remodeling leading to increased pulmonary vascular resistance and pulmonary arterial pressure. PAH is a highly morbid cardiopulmonary disease adversely affecting lifespan and quality of life. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rui‐Sheng, Loscalzo, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452304/ https://www.ncbi.nlm.nih.gov/pubmed/34132494 http://dx.doi.org/10.1002/psp4.12670

Ejemplares similares

Network determinants of cardiovascular calcification and repositioned drug treatments
por: Song, Euijun, et al.
Publicado: (2020)

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning
por: Loscalzo, Joseph
Publicado: (2022)

Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects
por: Paci, Paola, et al.
Publicado: (2022)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Uncovering common pathobiological processes between COVID‐19 and pulmonary arterial hypertension by integrating Omics data
por: Wang, Rui‐Sheng, et al.
Publicado: (2023)

MNBDR: A Module Network Based Method for Drug Repositioning
por: Chen, He-Gang, et al.
Publicado: (2020)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

Drug repositioning for enzyme modulator based on human metabolite-likeness
por: Lee, Yoon Hyeok, et al.
Publicado: (2017)

Repositioning drugs by targeting network modules: a Parkinson’s disease case study
por: Yue, Zongliang, et al.
Publicado: (2017)

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)

Drug repositioning using drug-disease vectors based on an integrated network
por: Lee, Taekeon, et al.
Publicado: (2018)

PROMISCUOUS: a database for network-based drug-repositioning
por: von Eichborn, Joachim, et al.
Publicado: (2011)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
por: Cheng, Feixiong, et al.
Publicado: (2012)

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
por: Ye, Hao, et al.
Publicado: (2014)

MD-Miner: a network-based approach for personalized drug repositioning
por: Wu, Haoyang, et al.
Publicado: (2017)

Drug repositioning based on individual bi-random walks on a heterogeneous network
por: Wang, Yuehui, et al.
Publicado: (2019)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022)

Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
por: Emig, Dorothea, et al.
Publicado: (2013)

Computational drug repositioning through heterogeneous network clustering
por: Wu, Chao, et al.
Publicado: (2013)

A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis
por: Li, Albert, et al.
Publicado: (2022)

Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
por: Wang, Rui-Sheng, et al.
Publicado: (2023)

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
por: Zhang, Yuchen, et al.
Publicado: (2022)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

Computational drug repositioning using meta-path-based semantic network analysis
por: Tian, Zhen, et al.
Publicado: (2018)

HeTDR: Drug repositioning based on heterogeneous networks and text mining
por: Jin, Shuting, et al.
Publicado: (2021)

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks
por: Huang, Weihong, et al.
Publicado: (2022)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
por: Wang, Kejian, et al.
Publicado: (2016)

Neurohormonal modulation in pulmonary arterial hypertension
por: Peters, Eva L., et al.
Publicado: (2021)

Hybrid attentional memory network for computational drug repositioning
por: He, Jieyue, et al.
Publicado: (2020)

Drug repositioning based on weighted local information augmented graph neural network
por: Meng, Yajie, et al.
Publicado: (2023)

Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension
por: White, Kevin, et al.
Publicado: (2012)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children
por: Gao, Huan, et al.
Publicado: (2021)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a159aljrqnib055l9scj4rjrcg